Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Thursday, 18 March 2021, 21:00 HKT/SGT

Source: Telewellness Ltd
CPS Health Care and Telewellness Present the Rating of COVID Technologies on a Lifetime Award

LONDON, Mar 18, 2021 - (ACN Newswire) - Recently Telewellness has announced a new investment partnership, with the goal of efficiently accelerating action against the COVID-19 pandemic, through mass adoption of trusted and rated COVID technologies.

To make that happen, CPS Health Care and Telewellness UK announced a joint commitment to support an interdisciplinary expert panel, which will rate COVID technologies and reward the best scientists and contributors in this field.

Coronavirus has evolved two separate traits that allow it to spread more easily. Firstly, it infects carriers who don't experience symptoms, who in turn transmit the virus to others. Secondly it mutates, with new strains becoming more dangerous. Vaccines are either less effective or ineffective against some of the new strains.

Everybody with the ability to fight against this disease should act now, whilst scientists remain at the front line of the fight. The company is ready to reward the most active influencers and scientists, through the Lifetime Award Program in which an expert community will rate COVID technologies with the help of a public vote.

In the interest of humanity, the team must take all steps possible to act against the current threat. They are advocating the pooling of resources by experts and influencers, to drive mass adoption of only the most trusted solutions against the disease.

Telewellness UK aims to be a channel for distribution of digital health and other innovative technologies.

About Telewellness & CPS Health Care GmbH

Telewellness is a united global group of influencers and biomedical professionals and they are facilitating a non-profit award program for trusted and innovative COVID technologies.

CPS Health Care GmbH is German company led by a former Ernst &Young partner.

Telewellness UK is a digital health-sharing economy platform, created following the Davos forum in 2020. Telewellness has developed an eco-system for sharing its benefits with members of Healthclub.

Healthclub provides the most innovative and personalized health-span technologies to its subscribers. Its goal is to fund scientific research, to publish the results to its members and to create a freely distributed AI based shield for health and mental wellness.

Lifetime Award goals:

To unite scientists and the public in rating the effectiveness of innovative COVID technologies, they have created the first panel of experts, scientists, social media influencers and thought leaders, and tasked them to rate COVID technologies.

The top scientific breakthrough for 2020 was the understanding of SARS-CoV-2 and how it affects COVID-19 - and then developing multiple vaccines.

Coronavirus separates people, but we should strive to stand united. The most important scientific breakthroughs should be accelerated, and significantly contributing innovators should be rewarded for their efforts.

For reference
Lifetime Award official website:

Media contact
Company: Telewellness Ltd
Contact: Eduard Musinschi
Telephone: +447376116343

SOURCE: Telewellness Ltd

Topic: Press release summary
Source: Telewellness Ltd
From the Asia Corporate News Network

Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

Latest Press Releases
Singapore's Kris Infotech acquires majority stake in AGS Tek Partners, plans major US expansion  
July 26, 2021 08:00 HKT/SGT
HKTDC twin jewellery events open today  
July 25, 2021 19:00 HKT/SGT
Onomy Protocol Opens the Door For Institutions To Take On DeFi  
July 24, 2021 04:00 HKT/SGT
Plato Data and Blockleaders Partner to Leverage Plato's W3 Blockchain Platform  
July 23, 2021 18:00 HKT/SGT
Central Global Continues with Proactive Business Sustainability Measures Despite Lockdown  
July 23, 2021 11:30 HKT/SGT
Dynafront Successfully Lists on LEAP Market of Bursa Malaysia  
July 23, 2021 10:30 HKT/SGT
Eisai: FDA Approves LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma  
July 23, 2021 08:17 HKT/SGT
Cuentas and WaveMax Sign an Exclusive and Definitive JV Agreement for 1,000 Locations to Offer Advertising on WiFi6 Next Generation Patented Technology in Cuentas' "Bodegas" Network throughout the USA  
July 23, 2021 06:00 HKT/SGT
Sino Biopharmaceutical Donates Cash and Supplies Valued at RMB10 Million to Support Henan for Flood Relief and Preventing Epidemic  
July 22, 2021 19:26 HKT/SGT
Kristof Schoffling's Move Digital Sets Sublime Standards for Enterprise Blockchain Advisory  
July 22, 2021 18:00 HKT/SGT
More Press release >>
More >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: